Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Ophthalmology Science, 2026
Associations of Host Genetics and Plasma Proteomics with Incident Age-related Macular Degeneration in Persons with AIDS

Hunt P., Sezgin E., Olshen A. et al.

Olink Explore 3072/384OphthalmologyPathophysiologyPlasma

BMC Medicine, 2026
Social vulnerability index and inflammation: a proteomic analysis linking social context to biological risk in older black adults

Yaskolka Meir A., Adeola H., Tasaki S. et al.

Olink Target 96EpidemiologyPathophysiologyPlasma

ACR Open Rheumatology, 2026
Reproducible Molecular Subtypes in Systemic Lupus Erythematosus Are Associated With Disease Activity, Serology, and Distinct Trajectories Over Time

Seridi L., Myshkin E., Noss E. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPatient StratificationSerum

Genome Medicine, 2026
Multi-omics profiles of sex hormone-binding globulin are associated with subclinical atherosclerosis in men with HIV

Wang Y., Xue X., Usyk M. et al.

Olink Explore 3072/384CVDInfectious DiseasesPathophysiologyPlasma

Journal of Molecular Medicine, 2026
Proteomic analysis reveals divergent inflammatory mechanisms of COVID-associated Guillain-Barré syndrome

Ulutekin C., Can A., Súkeníková L. et al.

Olink Target 96Immunological & Inflammatory DiseasesNeurologyPathophysiologySerumCSF

Journal of Proteome Research, 2026
Identification of Age-Associated Circulating Proteins and Lipids in 3800 Comorbidity-Enriched Older Adults from Japan-Based Cohorts Using Olink Assays and MRM Mass Spectrometry

Tokuoka S., Hamano F., Kobayashi A. et al.

Olink Target 96Olink Target 48AgingTechnical EvaluationPlasmaSerum

Medicine, 2026
Causal effects of circulating inflammatory proteins on COPD: A Mendelian randomization study

Long H., Chen D., Chu L. et al.

Olink Target 96Respiratory DiseasesPathophysiologyPlasma

Medicine, 2026
Gut microbiota influences gastric cancer through the mediation of inflammatory proteins: A Mendelian randomization analysis

Yu C., Wang F., Zhang X. et al.

Olink Target 96OncologyPathophysiologyPlasma

Journal of Advanced Research, 2026
Processed meat intake and incident gout: Integrated evidence from epidemiology, plasma proteomics, and machine learning

Wang Z., Shi D., Pan X. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesOrthopedicsPathophysiologyPlasma

Journal of the American Heart Association, 2026
Proteomics‐Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Adverse Cardiovascular Outcomes in the General Population: Insights From the UK Biobank

Sakr S., Medina‐Inojosa J., Liu C. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

Diabetes, Obesity and Metabolism, 2026
First‐Line Dapagliflozin, Metformin, or Combination Therapy in Type 2 Diabetes: Vascular and Molecular Outcomes of a Randomised Controlled Trial

Chee Y., Acharyya S., Liew H. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

Nature Cardiovascular Research, 2026
Depth of neutrophil mobilization stratifies survival in ST-elevation myocardial infarction

Richter M., von Göwels J., Fähndrich M. et al.

Olink Target 48CVDPathophysiologyPatient StratificationPlasma

Communications Medicine, 2026
Integrative proteogenomic analyses identify plasma proteins that impact the risk of ischemic stroke

Belbasis L., von Ende A., Gajendragadkar P. et al.

Olink Explore 3072/384CVDNeurologyPathophysiologyPlasma

Scientific Reports, 2026
Less severe endothelial injury and vascular pathway activation in SARS-CoV-2 Omicron variant compared to Alpha

Tiezzi M., Fortini F., Vandenbempt V. et al.

Olink Target 96CVDInfectious DiseasesPathophysiologyPlasma

Acta Pharmaceutica Sinica B, 2026
Reprogramming gut microbiota and targeting CXCL1: The multifaceted mechanism of PLP1 in ameliorating alcohol-induced liver disease

Yang Z., Lv Q., Xu Q. et al.

Olink Target 96 MouseHepatologyPathophysiologyMouse Tissue Lysate

The Lancet Rheumatology, 2026
Interferon-α as a precision medicine tool in Sjögren's disease: a cohort and experimental medicine study

Forbes D., Jorgacevic I., Tarn J. et al.

Olink Target 96Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma

The American Journal of Clinical Nutrition, 2026
Height variation independent of known genetic variants and health in later life: a cohort study

Zhang Y., Li Y., Xue X. et al.

Olink Explore 3072/384Wider Proteomics StudiesEpidemiologyPathophysiologyPlasma

JACC: Basic to Translational Science, 2026
Plasma Proteomic Signatures of Left Atrial Dysfunction and Cerebral Small Vessel Disease

Tan E., Sim M., Choi H. et al.

Olink Explore 3072/384CVDNeurologyPathophysiologyPlasma

Metabolism, 2026
Pathophysiology-based subtypes of individuals at high risk of type 2 diabetes: multi-omics profiles and lifestyle differences across subtypes

Deng K., Hameete A., Schrauwen P. et al.

Olink Explore 3072/384Metabolic DiseasesPatient StratificationPlasma

Clinical Gastroenterology and Hepatology, 2026
Coffee Consumption and Improved Liver Outcomes: Clinical, Imaging, and Proteomic Evidence From the UK Biobank

Kim H., Rezaee-Zavareh M., Wang Y. et al.

Olink Explore 3072/384HepatologyNutritional SciencePathophysiologyPlasma

4265 publications